SANNA, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 153
EU - Europa 120
AS - Asia 95
SA - Sud America 16
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 7
Totale 399
Nazione #
US - Stati Uniti d'America 145
RU - Federazione Russa 63
SG - Singapore 46
IT - Italia 34
CN - Cina 16
BR - Brasile 14
VN - Vietnam 13
HK - Hong Kong 10
GB - Regno Unito 7
BD - Bangladesh 4
DE - Germania 4
FR - Francia 4
BJ - Benin 3
CA - Canada 3
MX - Messico 3
NG - Nigeria 3
ES - Italia 2
KR - Corea 2
PL - Polonia 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
CG - Congo 1
CO - Colombia 1
GT - Guatemala 1
HN - Honduras 1
IE - Irlanda 1
IN - India 1
MT - Malta 1
NP - Nepal 1
PK - Pakistan 1
PY - Paraguay 1
SE - Svezia 1
TG - Togo 1
Totale 392
Città #
San Jose 28
Singapore 27
Ashburn 26
Moscow 17
Dallas 15
Council Bluffs 11
Hong Kong 10
Verona 9
Beijing 7
Santa Clara 6
Ho Chi Minh City 5
Los Angeles 5
Milan 5
Padua 4
Phoenix 4
Tianjin 4
Chicago 3
Cotonou 3
Hanoi 3
Houston 3
Abuja 2
Annandale 2
London 2
New York 2
Redondo Beach 2
San Francisco 2
São Paulo 2
Tarano 2
Warsaw 2
Araguaína 1
Asunción 1
Belfast 1
Biên Hòa 1
Bogotá 1
Brazzaville 1
Brussels 1
Bắc Giang 1
Castelfranco Veneto 1
Centro Municipality 1
Chennai 1
Chesapeake 1
Ciserano 1
City of London 1
Comitán 1
Da Nang 1
Denver 1
Dhaka 1
Elgin 1
England 1
Espera Feliz 1
Esquipulas 1
Fayetteville 1
Figino 1
Frankfurt am Main 1
Genoa 1
Guanambi 1
Inman 1
Joanópolis 1
Kathmandu 1
Lagos 1
Lomé 1
Londrina 1
Luziânia 1
Madrid 1
Manocalzati 1
McKinney 1
Mexico City 1
Milwaukee 1
Modugno 1
Montes Claros 1
Montreal 1
Msida 1
Munich 1
New Bedford 1
North Bergen 1
North Hollywood 1
Offenbach 1
Orem 1
Paraisópolis 1
Paris 1
Penápolis 1
Plano 1
Poplar 1
Raleigh 1
Rawalpindi 1
Rio Claro 1
Rome 1
San Pedro Sula 1
Santa Ana 1
Seattle 1
São Leopoldo 1
São Luís 1
Sóc Trăng 1
Talavera de la Reina 1
Toronto 1
Turin 1
Winnipeg 1
Totale 281
Nome #
Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study 155
Venetoclax based regimens in octogenarian CLL patients: efficacy, safety and comparison to BTKi in a multicenter cohort 99
How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia 83
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real-World Study 22
Real-world safety and effectiveness of zanubrutinib vs ibrutinib in CLL: the CLL-ZANU2024 Italian cohort 15
Real‐life efficacy and safety of vemurafenib plus rituximab in relapsed or refractory hairy‐cell leukemia: A multicenter Italian retrospective study (HCL‐PG03R) 14
Rethinking the feasibility and safety of venetoclaxobinutuzumab in chronic lymphocytic leukemia: nontraditional factors may play a role in clinical practice 11
Totale 399
Categoria #
all - tutte 1.778
article - articoli 1.778
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.556


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20235 0 0 0 0 0 0 2 1 0 1 1 0
2023/20249 1 1 1 0 1 2 1 1 0 0 0 1
2024/202548 1 1 1 5 1 1 0 0 10 2 9 17
2025/2026246 13 11 15 40 65 14 18 23 12 12 14 9
2026/202791 13 34 18 26 0 0 0 0 0 0 0 0
Totale 399